AFP and testicular cancer: In further investigations of the dose–response effect between MoM quartile categories of maternal AFP serum levels and testicular cancer risk, we detected a U-shaped response for seminomas, but an increasing response over the first three quartiles to a plateau for nonseminomas, albeit with non-significant trend estimates (Table S1).